Cytokinetics, Inc. (CYTK) Posts Q2 Loss of 23c/Share
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $78.78 +0.86%
EPS Growth %: -46.4%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -46.4%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q2 EPS of ($0.23), $0.09 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $7.8 million versus the consensus estimate of $7.01 million.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Hyperscale Data launches $300M at-the-market stock offering
- Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
